Convalescence: Clinical Trials

1 trial for Convalescence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Convalescence: new trials by email Literature Review of Convalescence trials Research Report on Convalescence

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
Nerver growth factor (NGF) injection, Placebo injection, EA intervention - Ischemic Stroke
Phase 4UnknownThe Third Affiliated hospital of Zhejiang Chinese Medical University2882022-04-012022-07-28

Narrower conditions

Hereditary Sensory and Autonomic Neuropathies (1)  ·  Ischemic Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Nervous System Diseases (1)  ·  Nervous System Malformations (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Injections (1)  ·  Nerve Growth Factor (1)

Sponsors

The Third Affiliated hospital of Zhejiang Chinese Medical University (1)

Countries

China (1)

Results publications

PMID 1135616, PMID 23152677, PMID 24799137, PMID 25770310, PMID 25870613, PMID 26077459, PMID 2855531, PMID 28626052, PMID 29487073, PMID 29729645, PMID 29984566, PMID 30762779, PMID 33262243, PMID 33488759, PMID 34770113, PMID 39033586, PMID 42477731, PMID 8054244